MedTrace Logo

Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation

NCT01473082 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 251

Last updated 2020-08-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether patients with trochanteric fractures being treated with a Proximal Femoral Nail Antirotation (PFNA) and augmentation can better be mobilized than patients without augmentation.

Conditions

  • Hip Fractures
  • Closed Fracture of Hip

Interventions

DEVICE

PFNA Augmentation (Synthes)

Proximal Femoral Nail Antirotation (PFNA) Augmentation (with Traumacem V+)

DEVICE

PFNA (Synthes)

Proximal Femoral Nail Antirotation (PFNA)

Sponsors & Collaborators

  • AO Clinical Investigation and Publishing Documentation

    lead OTHER

Principal Investigators

  • Andreas Faeh · AO Clinical Investigation and Documentation, Davos, Switzerland

  • Christian Kammerlander, MD · Medical University of Innsbruck, Austria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Austria
  • Belgium
  • Germany
  • Israel
  • Norway
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01473082 on ClinicalTrials.gov